Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

The cutting-edge nanoparticle system, engineered to deliver therapeutic molecules directly to the digestive tract, has shown significant potential to prevent diet-induced obesity.

But a new study found that the results may not look the same ... Overall, the researchers discovered that people who took a medication for obesity lost more weight than those who took it for type 2 ...

Researchers have developed a revolutionary magnetogenetics technology that can control brain circuits non-invasively using ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

My own experience initially led me to believe that weight loss was just a matter of commitment and a modicum of self-control.

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented ...

PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...

John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.